
Kade Ariani
Examiner (ID: 16851, Phone: (571)272-6083 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651 |
| Total Applications | 1073 |
| Issued Applications | 646 |
| Pending Applications | 111 |
| Abandoned Applications | 356 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17243812
[patent_doc_number] => 20210363555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => REDUCING INSOLUBLE DEPOSIT FORMATION IN ETHANOL PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/208696
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208696
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208696 | Reducing insoluble deposit formation in ethanol production | Mar 21, 2021 | Issued |
Array
(
[id] => 16932764
[patent_doc_number] => 20210198653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => DELIVERING ENZYME USING AN INJECTABLE HYDROGEL DEPOT
[patent_app_type] => utility
[patent_app_number] => 17/201526
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201526 | DELIVERING ENZYME USING AN INJECTABLE HYDROGEL DEPOT | Mar 14, 2021 | Pending |
Array
(
[id] => 18477088
[patent_doc_number] => 11690812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Methods and compositions for the treatment of steatosis-associated disorders
[patent_app_type] => utility
[patent_app_number] => 17/190018
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 30
[patent_no_of_words] => 18278
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190018 | Methods and compositions for the treatment of steatosis-associated disorders | Mar 1, 2021 | Issued |
Array
(
[id] => 18077820
[patent_doc_number] => 20220403432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHOD FOR PREPARING CHONDROITIN SULFATE OLIGOSACCHARIDES WITH C5 PROTEIN TARGETING PROPERTY, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/772359
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772359
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772359 | METHOD FOR PREPARING CHONDROITIN SULFATE OLIGOSACCHARIDES WITH C5 PROTEIN TARGETING PROPERTY, AND APPLICATION THEREOF | Feb 2, 2021 | Abandoned |
Array
(
[id] => 18404565
[patent_doc_number] => 20230165916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES OF DIGESTIVE SYSTEM OR COLITIS, COMPRISING REOVIRUS AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/995135
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995135 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES OF DIGESTIVE SYSTEM OR COLITIS, COMPRISING REOVIRUS AS ACTIVE INGREDIENT | Jan 28, 2021 | Pending |
Array
(
[id] => 19609014
[patent_doc_number] => 12157881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Use of a defoamer for maintaining dispersed morphology in submerged fungal fermentation
[patent_app_type] => utility
[patent_app_number] => 17/793942
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9071
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793942 | Use of a defoamer for maintaining dispersed morphology in submerged fungal fermentation | Jan 21, 2021 | Issued |
Array
(
[id] => 18685438
[patent_doc_number] => 11781161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Enzymatic enrichment of n-3 fatty acids in the form of glycerides
[patent_app_type] => utility
[patent_app_number] => 17/147734
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13909
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 481
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147734 | Enzymatic enrichment of n-3 fatty acids in the form of glycerides | Jan 12, 2021 | Issued |
Array
(
[id] => 18177425
[patent_doc_number] => 20230038154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => SUCROSE NEGATIVE STREPTOCOCCUS THERMOPHILUS FOR USE IN PREPARATION OF FERMENTED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/758150
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758150 | SUCROSE NEGATIVE STREPTOCOCCUS THERMOPHILUS FOR USE IN PREPARATION OF FERMENTED PRODUCTS | Dec 29, 2020 | Issued |
Array
(
[id] => 16990272
[patent_doc_number] => 20210228692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => INTRAVENTRICULAR ENZYME DELIVERY FOR LYSOSOMAL STORAGE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/137060
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137060 | INTRAVENTRICULAR ENZYME DELIVERY FOR LYSOSOMAL STORAGE DISEASES | Dec 28, 2020 | Abandoned |
Array
(
[id] => 18178181
[patent_doc_number] => 20230038910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/758212
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758212 | LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, COMPRISING SAME | Dec 28, 2020 | Issued |
Array
(
[id] => 16901105
[patent_doc_number] => 20210180021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/126859
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126859 | Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof | Dec 17, 2020 | Abandoned |
Array
(
[id] => 18142830
[patent_doc_number] => 20230016674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => Method for obtaining chitin and/or chitosan using two enzymatic hydrolyses
[patent_app_type] => utility
[patent_app_number] => 17/782236
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782236 | Method for obtaining chitin and/or chitosan using two enzymatic hydrolyses | Dec 16, 2020 | Abandoned |
Array
(
[id] => 19166000
[patent_doc_number] => 11981890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Method for preparing cultures of lactic acid bacteria
[patent_app_type] => utility
[patent_app_number] => 17/784055
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15093
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784055 | Method for preparing cultures of lactic acid bacteria | Dec 9, 2020 | Issued |
Array
(
[id] => 17368345
[patent_doc_number] => 20220023397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => USE OF PROUROKINASE AND ITS VARIANTS AGAINST COAGULOPATHY CAUSED BY VIRUSES
[patent_app_type] => utility
[patent_app_number] => 17/105867
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105867
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105867 | Use of prourokinase and its variants against coagulopathy caused by viruses | Nov 26, 2020 | Issued |
Array
(
[id] => 18091170
[patent_doc_number] => 20220409511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT CELLULITE
[patent_app_type] => utility
[patent_app_number] => 17/778816
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778816 | HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT CELLULITE | Nov 26, 2020 | Abandoned |
Array
(
[id] => 16671325
[patent_doc_number] => 20210060088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/098243
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098243 | Compositions and methods for | Nov 12, 2020 | Issued |
Array
(
[id] => 16657785
[patent_doc_number] => 20210054421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => ANAPLEROTIC OIL PRODUCTION IN MICROBIALS
[patent_app_type] => utility
[patent_app_number] => 17/090569
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090569 | Anaplerotic oil production in microbials | Nov 4, 2020 | Issued |
Array
(
[id] => 16822635
[patent_doc_number] => 20210137928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => ENHANCED CAFFEINATED BEVERAGE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/084777
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17084777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/084777 | Enhanced caffeinated beverage composition | Oct 29, 2020 | Issued |
Array
(
[id] => 20239617
[patent_doc_number] => 12419921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Methods of promoting SCFA production by gut microbiota
[patent_app_type] => utility
[patent_app_number] => 17/769125
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 41
[patent_no_of_words] => 17228
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769125 | Methods of promoting SCFA production by gut microbiota | Oct 15, 2020 | Issued |
Array
(
[id] => 20142302
[patent_doc_number] => 12376615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Composition for improving respiratory diseases using Lactobacillus plantarum strain
[patent_app_type] => utility
[patent_app_number] => 17/767181
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 1095
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767181
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767181 | Composition for improving respiratory diseases using Lactobacillus plantarum strain | Oct 7, 2020 | Issued |